Clinical Trials at University of Wisconsin Carbone Cancer Center - Johnson Creek
As of August 2026, 14 paid clinical trials are recruiting at University of Wisconsin Carbone Cancer Center - Johnson Creek in Johnson Creek, Wisconsin. Active studies at this site cover conditions such as Anatomic Stage II Breast Cancer AJCC v8, Prostate Adenocarcinoma and Anatomic Stage I Breast Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
14 clinical trials at University of Wisconsin Carbone Cancer Center - Johnson Creek
·Clear filters·Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Common conditions studied in Johnson Creek
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Prostate Adenocarcinoma (2 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage III Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (1 active study)
- Anatomic Stage IIIB Breast Cancer AJCC v8 (1 active study)
Leading research sponsors in Johnson Creek
- NRG Oncology
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Johnson Creek?
There are approximately 14 recruiting clinical trials in Johnson Creek, Wisconsin listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Johnson Creek pay participants?
Most recruiting trials in Johnson Creek compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Johnson Creek?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Johnson Creek?
The most common conditions under active study in Johnson Creek include Anatomic Stage II Breast Cancer AJCC v8 (3), Prostate Adenocarcinoma (2), Anatomic Stage I Breast Cancer AJCC v8 (1), Anatomic Stage III Breast Cancer AJCC v8 (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Johnson Creek?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Johnson Creek on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Johnson Creek?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Johnson Creek?
Recruiting research sites in Johnson Creek include University of Wisconsin Carbone Cancer Center - Johnson Creek, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Johnson Creek right now?
The largest active categories in Johnson Creek are Cancer & tumors (14). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.